The Israeli COVID19 drug reportedly with a 100% success rate even among severely ill patients is being tested in the United States for the first time. Pluristem Therapeutics Inc., a biotech company based in Haifa/Israel, reported that seven patients who were at a high risk of death due to respiratory failure, multi-system organ failure, including
Read more